My current research interests broadly encompass:
Using economic evaluation (e.g., cost-effectiveness analysis) and simulation modeling to improve the efficiency of healthcare and population-level interventions in the US and in low- and middle-income countries
Developing and applying decision science tools and other research methods to advance health equity
Evaluating the costs, benefits, and cost-effectiveness of high-cost or novel healthcare technologies and therapies
This systematic review found that multicomponent interventions may be used to increase vaccination intent and uptake among adults, which may be relevant to current COVID-19 vaccination efforts in low-resource settings.
Published in Vaccine Co-authored with Janamarie M. Perroud, Shad Soldano, and Abram Wagner.
In this modeling study, broad income support policies, like universal basic income, were estimated to avert the most deaths among working-age adults, although targeted approaches, like poverty alleviation, may also avert thousands of deaths. Results were sensitive to several inputs, primarily the income group–specific mortality rates used.
Published in JAMA Health Forum. Co-authored with Nicholas Miller, Ellen Kim DeLuca, Brad Iott, Amanda Mauri, Daniel Eisenberg, and David W. Hutton.
Some of my collaborative papers or projects in progress include:
"Using mHealth to reach female entertainment workers in Cambodia: an economic evaluation of the Mobile Link trial" (under review)
"Achieving malaria testing and treatment targets in Mozambique: a cost-effectiveness analysis" (under review)
"Cost-effectiveness of rituximab in treatment-resistant minimal change disease and focal segmental glomerulosclerosis" (research in progress)
"Projected cost-effectiveness of vaccination against COVID-19 in pediatric and adult populations" (research in progress)